PTC
GH icon

Private Trust Company’s Guardant Health GH Stock Holding History

Private Trust Company’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-214
Closed -$13.4K – 2587
2025
Q3 		$13.4K Buy
214
+111
+108% +$6.04K ﹤0.01% 1798
2025
Q2 		$5.36K Hold
103
– – ﹤0.01% 2041
2025
Q1 		$4.39K Buy
+103
New +$4.44K ﹤0.01% 2082
2024
Q1 		– Sell
-72
Closed -$1.95K – 2290
2023
Q4 		$1.95K Hold
72
– – ﹤0.01% 2136
2023
Q3 		$2.13K Hold
72
– – ﹤0.01% 2105
2023
Q2 		$2.58K Buy
+72
New +$2.07K ﹤0.01% 2062
2022
Q3 		– Sell
-125
Closed -$5K – 2088
2022
Q2 		$5K Buy
+125
New +$6.19K ﹤0.01% 1738

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Private Trust Company's GH Position: Q4 2025 in Review

Private Trust Company sold out of Guardant Health (GH) in Q4 2025, closing a stake of 214 shares — an estimated $13.4K sold.

Private Trust Company first reported a position in GH in Q2 2022 and held it in 7 quarters. The position peaked at $13.4K in Q3 2025. 497 funds tracked by Wall St. Rank hold GH as of Q4 2025.

  • Private Trust Company reported no remaining Guardant Health position as of Q4 2025 after selling out during the quarter.
  • Private Trust Company sold 214 Guardant Health shares in Q4 2025, an estimated $13.4K.
  • Private Trust Company first reported a position in Guardant Health in Q2 2022 and held it in 7 quarters.
  • Private Trust Company's Guardant Health position peaked at $13.4K in Q3 2025.
  • 497 funds tracked by Wall St. Rank held Guardant Health as of Q4 2025.

Based on Private Trust Company's 13F filing for Q4 2025, filed 26 Jan 2026.